EUVIMEDEUVIMED entdecken
Open Access

Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine

Jonna B Westover, Kie Hoon Jung, Cigdem Alkan, Kirsten M Boardman, Arnaud J Van Wettere, Craig Martens, Inioska Rojas, Philip Hicks, Aaron J Thomas, Manohar T Saindane, Gregory R Bluemling, Shuli Mao und 6 weitere

Journal of Virology · 2024

DOI: 10.1128/jvi.00132-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Jonna B Westover und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, USA. Hauptthemen laut MEDLINE: Bunyaviridae, Bunyaviridae Infections, Uracil Nucleotides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, ORFDO NIH HHS, CLC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heartland virus (HRTV) is an emerging tick-borne bandavirus that causes a febrile illness of varying severity in humans, with cases reported in eastern and midwestern regions of the United States. No vaccines or approved therapies are available to prevent or treat HRTV disease. Here, we describe the genetic changes, natural history of disease, and pathogenesis of a mouse-adapted HRTV (MA-HRTV) that is uniformly lethal in 7- to 8-week-old AG129 mice at low challenge doses. We used this model to assess the efficacy of the ribonucleoside analog, 4′-fluorouridine (EIDD-2749), and showed that once-daily oral treatment with 3 mg/kg of drug, initiated after the onset of disease, protects mice against lethal MA-HRTV challenge and reduces viral loads in blood and tissues. Our findings provide insights into HRTV virulence and pathogenesis and support further development of EIDD-2749 as a therapeutic intervention for HRTV disease. IMPORTANCE More than 60 cases of HRTV disease spanning 14 states have been reported to the United States Centers for Disease Control and Prevention. The expanding range of the Lone Star tick that transmits HRTV, the growing population of at-risk persons living in geographic areas where the tick is abundant, and the lack of antiviral treatments or vaccines raise significant public health concerns. Here, we report the development of a new small-animal model of lethal HRTV disease to gain insight into HRTV pathogenesis and the application of this model for the preclinical development of a promising new antiviral drug candidate, EIDD-2749. Our findings shed light on how the virus causes disease and support the continued development of EIDD-2749 as a therapeutic for severe cases of HRTV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BunyaviridaeBunyaviridae InfectionsUracil NucleotidesAnimalsHumansMiceTicksUnited States

Stichwörter der Autor:innen

Heartland bandavirusHeartland virusanimal modelsantiviral agentsbandavirusmolecular geneticsvirulence determinants

Substanzen

4'-fluorouridineUracil Nucleotides

Autor:innen und Institutionen

  • Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, USA.
  • Institute for Antiviral Research, Utah State University, Logan, Utah, USA.
  • Department of Pathology, The University of Texas Medical Branch, Galveston, Texas, USA.
  • Utah Veterinary Diagnostic Laboratory, Logan, Utah, USA.
  • Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Tetsuro Ikegami, Brian B Gowen

Förderung

  • NIAID NIH HHS
  • ORFDO NIH HHS
  • CLC NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | NIAID | Division of Intramural Research
  • DOD | Defense Threat Reduction Agency
  • Institute for Human Infections and Immunity, University of Texas Medical Branch

Zitieren

APA

Westover, J. B., Jung, K. H., Alkan, C., Boardman, K. M., Van Wettere, A. J., Martens, C., Rojas, I., Hicks, P., Thomas, A. J., Saindane, M. T., Bluemling, G. R., Mao, S., Kolykhalov, A. A., Natchus, M. G., Bates, P., Painter, G. R., Ikegami, T., & Gowen, B. B. (2024). Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine. Journal of Virology. https://doi.org/10.1128/jvi.00132-24

Vancouver

Westover JB, Jung KH, Alkan C, Boardman KM, Van Wettere AJ, Martens C, et al. Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine. Journal of Virology. 2024. doi:10.1128/jvi.00132-24

BibTeX
@article{Westover2024,
  author = {Westover, Jonna B and Jung, Kie Hoon and Alkan, Cigdem and Boardman, Kirsten M and Van Wettere, Arnaud J and Martens, Craig and Rojas, Inioska and Hicks, Philip and Thomas, Aaron J and Saindane, Manohar T and Bluemling, Gregory R and Mao, Shuli and Kolykhalov, Alexander A and Natchus, Michael G and Bates, Paul and Painter, George R and Ikegami, Tetsuro and Gowen, Brian B},
  title = {Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.00132-24}
}
Kostenlos starten →